tiprankstipranks
Trending News
More News >
Tsumura & Co. (JP:4540)
:4540
Advertisement

Tsumura & Co (4540) Price & Analysis

Compare
2 Followers

4540 Stock Chart & Stats


Financials

Options Prices

Currently, No data available
---

Ownership Overview

5.03%89.88%
Insiders
5.03%
Mutual Funds
― Other Institutional Investors
89.88% Public Companies and
Individual Investors

4540 FAQ

What was Tsumura & Co.’s price range in the past 12 months?
Tsumura & Co. lowest stock price was ¥3306.00 and its highest was ¥5138.00 in the past 12 months.
    What is Tsumura & Co.’s market cap?
    Tsumura & Co.’s market cap is $280.48B.
      When is Tsumura & Co.’s upcoming earnings report date?
      Tsumura & Co.’s upcoming earnings report date is Jul 31, 2025 which is in 5 days.
        How were Tsumura & Co.’s earnings last quarter?
        Tsumura & Co. released its earnings results on May 12, 2025. The company reported ¥77.27 earnings per share for the quarter, missing the consensus estimate of ¥124.547 by -¥47.277.
          Is Tsumura & Co. overvalued?
          According to Wall Street analysts Tsumura & Co.’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
            Does Tsumura & Co. pay dividends?
            Tsumura & Co. pays a Semiannually dividend of ¥68 which represents an annual dividend yield of 3.71%. See more information on Tsumura & Co. dividends here
              What is Tsumura & Co.’s EPS estimate?
              Tsumura & Co.’s EPS estimate is 90.94.
                How many shares outstanding does Tsumura & Co. have?
                Tsumura & Co. has 76,758,360 shares outstanding.
                  What happened to Tsumura & Co.’s price movement after its last earnings report?
                  Tsumura & Co. reported an EPS of ¥77.27 in its last earnings report, missing expectations of ¥124.547. Following the earnings report the stock price went down -15.16%.
                    Which hedge fund is a major shareholder of Tsumura & Co.?
                    Currently, no hedge funds are holding shares in JP:4540

                    Company Description

                    Tsumura & Co.

                    Tsumura & Co (4540) is a leading Japanese pharmaceutical company specializing in the research, development, production, and distribution of Kampo medicine, a traditional form of Japanese herbal medicine. The company focuses on providing high-quality Kampo products, which are derived from natural ingredients and are used for various therapeutic applications. With a strong emphasis on traditional and holistic approaches, Tsumura & Co aims to integrate Kampo medicine into modern healthcare practices, serving both domestic and international markets.

                    4540 Stock 12 Month Forecast

                    Average Price Target

                    ¥4,296.24
                    ▲(17.19%Upside)
                    {"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"2579":"¥2,579","5690":"¥5,690","3356.75":"¥3,356.8","4134.5":"¥4,134.5","4912.25":"¥4,912.3"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":5689.999999958747,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">¥5.69K</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":4296.2417096225,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">¥4.30K</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":3599.9999999739,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">¥3.60K</span>\n  </div></div>","useHTML":true}}],"tickPositions":[2579,3356.75,4134.5,4912.25,5690],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"May<br/>2024","6":"Aug<br/>2024","9":"Nov<br/>2024","12":"Jun<br/>2025","25":"Jun<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,3355,3534.6153846122115,3714.2307692244226,3893.846153836634,4073.461538448845,4253.076923061057,4432.692307673268,4612.30769228548,4791.92307689769,4971.538461509902,5151.1538461221135,5330.769230734324,5510.3846153465365,{"y":5689.999999958747,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,3355,3427.4032084325,3499.806416865,3572.2096252974998,3644.61283373,3717.0160421625,3789.419250595,3861.8224590275,3934.22566746,4006.6288758925,4079.032084325,4151.4352927575,4223.83850119,{"y":4296.2417096225,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,3355,3373.846153844146,3392.692307688292,3411.5384615324383,3430.3846153765844,3449.2307692207305,3468.0769230648766,3486.923076909023,3505.7692307531693,3524.6153845973154,3543.4615384414615,3562.3076922856076,3581.1538461297537,{"y":3599.9999999739,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":2580.737,"date":1706745600000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":2643.927,"date":1709251200000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":3719.013,"date":1711929600000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":3671.483,"date":1714521600000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":3831.535,"date":1717200000000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":4003.226,"date":1719792000000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":3712.223,"date":1722470400000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":3824.744,"date":1725148800000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":3824.744,"date":1725148800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":4805.928,"date":1730419200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":4227.838,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":4324,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3355,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
                    Similar Stocks
                    Company
                    Price & Change
                    Follow
                    KYORIN Pharmaceutical Co.,Ltd.
                    Sumitomo Dainippon Pharma Co
                    Kissei Pharmaceutical Co
                    Hisamitsu Pharmaceutical Co
                    Torii Pharmaceutical Co
                    Popular Stocks
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis